Label: SODIUM CHLORIDE irrigant
- NDC Code(s): 0338-0051-44
- Packager: Baxter Healthcare Corporation
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: New Drug Application
Drug Label Information
Updated April 2, 2018
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
DESCRIPTION
0.9% Sodium Chloride Irrigation, USP in the Baxter Sterile Container System is a sterile, nonpyrogenic, isotonic solution for the preparation of slushed solution. It contains no antimicrobial agents. Composition, osmolarity, pH and ionic concentration are shown in Table 1.
Table 1 Size (mL)
Composition (g/L)
Osmolarity (mOsmol/L) (calc)
pH
Ionic Concentration
(mEq/L)Sodium Chloride, USP (NaCl)
Sodium
Chloride
0.9 % Sodium Chloride Irrigation, USP
1000
9
308
5.0 (4.5 to 7.0)
154
154
The Baxter Sterile Container System is designed to provide a slush container with a sterile exterior surface for use within the surgical field. Within the overwrap, the unit is packaged in a dispensing bag which maintains the sterility of this surface.
The flexible plastic slush container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by culture toxicity studies.
-
CLINICAL PHARMACOLOGY
Slushed solution is used to induce regional hypothermia in conditions such as certain open heart and kidney surgical procedures by direct application of slushed solution. The objective of regional hypothermia is to reduce cellular metabolic activity so that body tissues can tolerate a period of total or relative ischemia thereby inhibiting the formation and buildup of destructive autolytic enzymes and anaerobic by-products usually produced and accumulated in ischemic tissues.
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
-
PRECAUTIONS
General Precautions
Avoid prolonged direct contact between ice crystals and body tissues.
Experience in use of slushed solutions in pediatrics is limited.
Carcinogenesis, Mutagenesis, Impairment of Fertility
Studies performed with slushed 0.9% Sodium Chloride Irrigation, USP have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.
Pregnancy
Teratogenic Effects
Animal reproduction studies have not been conducted with slushed 0.9% Sodium Chloride Irrigation, USP. It is also not known whether slushed 0.9% Sodium Chloride Irrigation, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Slushed 0.9% Sodium Chloride Irrigation, USP should be given to a pregnant woman only if clearly needed.
Nursing Mothers
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when slushed 0.9% Sodium Chloride Irrigation, USP is administered to a nursing mother.
Pediatric Use
Safety and effectiveness of slushed 0.9% Sodium Chloride Irrigation, USP in pediatric patients have not been established by adequate and well controlled trials; however, the use of electrolyte solutions in the pediatric population is referenced in the medical literature. The warnings, precautions and adverse reactions identified in the label copy should be observed in the pediatric population.
Do not administer unless seals of outer dispensing bag are intact.
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
-
HOW SUPPLIED/STORAGE AND HANDLING
.9% Sodium Chloride Irrigation, USP in the Baxter Sterile Container System is supplied as follows:
Code
Size (mL)
NDC
DIN
2B7231
1000
0338-0051-44
786160
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Avoid freezing except during controlled slushing procedure. It is recommended that this product be stored at room temperature (25ºC); brief exposure up to 40ºC does not adversely affect this product.
-
DIRECTIONS FOR USE OF THE BAXTER STERILE CONTAINER SYSTEM
Guidelines for Preparation of Slush
The following instructions are intended only as guidelines for the preparation of slush using the Baxter Sterile Container System. The specific procedure necessary to achieve the desired slush consistency will depend on the type of freezer used, location of the product in the freezer, and the utilization of freezer capacity.
- 1.
- Remove product from shipping carton and place in freezer at a temperature between minus 4ºC and minus 15ºC for 2 to 6 hours. Note: A pre-cooled product will require less time to slush.
- 2.
- During the freezing process, remove product from freezer periodically and carefully massage to break up large frozen chunks of solution.
- 3.
- Return product to freezer and repeat procedure until desired slush consistency is obtained.
To Open: Use Aseptic Technique
A. To prepare unit outside the surgical field.
- 1.
- Tear overwrap down side at slit and remove dispensing bag which contains the slush container.
- 2.
- Allow unit to stand at room temperature for approximately 10 minutes to allow container material to regain flexibility.
- 3.
- Check that all the seals of the dispensing bag are intact including the tamper evident button. If any broken seals or holes are detected, discard unit as sterility may be impaired.
- 4.
- Grasp tab of dispensing bag and peel open (Figure 1). Remove wrapped inner slush container.
- 5.
- Grasp point of sterile transfer wrap (Figure 2), and pull forward then back to expose sterile slush container (Figure 3). Caution should be exercised to avoid touch contamination.
B. To transfer sterile slush container to the surgical field.
- 1.
- Using sterile gloved hands, remove slush container from the sterile transfer wrap (Figure 4). Place on surgical field or use immediately.
- 2.
- Grasp tab at top of slush container and peel directly across the width of the container with a steady motion (Figure 5).
- 3.
- Slush is ready for dispensing.
- SPL UNCLASSIFIED SECTION
-
PRINCIPAL DISPLAY PANEL - PACKAGING LABELING
1000 mL
2B7231NDC 0338-0051-44
Din 00786160NOT FOR INJECTION
0.9% Sodium Chloride
Irrigation, USP
Baxter Sterile Container SystemEACH 100 mL CONTAINS 900 mg SODIUM CHLORIDE
USP pH 5.0 (4.5 TO 7.0) mEq/L SODIUM 154
CHLORIDE 154 OSMOLARITY 308 mOsmol/L (CALC)
STERILE NONPYROGENIC SINGLE DOSE CONTAINERFOR USE ONLY IN SLUSH PREPARATION
FOR REGIONAL HYPOTHERMIASEE ACCOMPANYING DIRECTIONS FOR USE
DOSAGE AS DIRECTED BY A PHYSICIAN
CAUTION RX ONLYBaxter Logo
Baxter Healthcare Corporation
Deerfield IL 60015 USAMade in USA
Distributed in Canada by
Baxter Corporation
Misissauga ON L5N 0C2PL 146 Plastic
Baxter and PL 146 are trademarks of Baxter International Inc
-
INGREDIENTS AND APPEARANCE
SODIUM CHLORIDE
sodium chloride irrigantProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0338-0051 Route of Administration IRRIGATION Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE 9 g in 1000 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0338-0051-44 1000 mL in 1 BAG; Type 0: Not a Combination Product 05/17/1985 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA019319 05/17/1985 Labeler - Baxter Healthcare Corporation (005083209) Establishment Name Address ID/FEI Business Operations Baxter Healthcare Corporation 059140764 MANUFACTURE(0338-0051) , ANALYSIS(0338-0051) , PACK(0338-0051) , LABEL(0338-0051) , STERILIZE(0338-0051) Establishment Name Address ID/FEI Business Operations Baxter Healthcare Corporation 189326168 ANALYSIS(0338-0051) , MANUFACTURE(0338-0051) , LABEL(0338-0051) , PACK(0338-0051) , STERILIZE(0338-0051) Establishment Name Address ID/FEI Business Operations Baxter Healthcare Corporation 194684502 ANALYSIS(0338-0051)
